Prosecution Insights
Last updated: August 06, 2026
Application No. 18/294,744

METHOD FOR DETECTING AT LEAST ONE MEDICAL CONSUMABLE

Final Rejection §101§103
Filed
Feb 02, 2024
Priority
Aug 05, 2021 — DE 10 2021 120 443.7 +1 more
Examiner
LE, VU
Art Unit
2668
Tech Center
2600 — Communications
Assignee
Clinomic Medical GmbH
OA Round
2 (Final)
52%
Grant Probability
Moderate
3-4
OA Rounds
5m
Est. Remaining
60%
With Interview

Examiner Intelligence

Grants 52% of resolved cases
52%
Career Allowance Rate
22 granted / 42 resolved
-9.6% vs TC avg
Moderate +8% lift
Without
With
+7.9%
Interview Lift
resolved cases with interview
Typical timeline
2y 12m
Avg Prosecution
11 currently pending
Career history
55
Total Applications
across all art units

Statute-Specific Performance

§101
10.7%
-29.3% vs TC avg
§103
52.8%
+12.8% vs TC avg
§102
24.5%
-15.5% vs TC avg
§112
9.4%
-30.6% vs TC avg
Black line = Tech Center average estimate • Based on career data from 42 resolved cases

Office Action

§101 §103
Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Response to Amendment The amendment filed 6/22/2026 overcomes the following objection(s) and/or rejection(s): Objection to claims 1-28; Rejection of claims 1, 3, 7, 21, 27, 28 under 35 U.S.C. 101 SME. Claim Rejections - 35 USC § 101 35 U.S.C. 101 reads as follows: Whoever invents or discovers any new and useful process, machine, manufacture, or composition of matter, or any new and useful improvement thereof, may obtain a patent therefor, subject to the conditions and requirements of this title. Claim 28 rejected under 35 U.S.C. 101 because the claimed invention is directed to non-statutory subject matter. See MPEP 2106 and 2106.03 for guidance. The claim(s) does/do not fall within at least one of the four categories of patent eligible subject matter of a process, machine, manufacture, or composition of matter. “A computer program” as recited is not patent eligible subject matter because it is “software/data per se”. A recommended remedy for claiming a computer program is to have it embodied within a “non-transitory” computer readable medium. See also USPTO Published 2019 Patent Eligibility Guidance. Claim Rejections - 35 USC § 103 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. The factual inquiries for establishing a background for determining obviousness under 35 U.S.C. 103 are summarized as follows: 1. Determining the scope and contents of the prior art. 2. Ascertaining the differences between the prior art and the claims at issue. 3. Resolving the level of ordinary skill in the pertinent art. 4. Considering objective evidence present in the application indicating obviousness or nonobviousness. Claim(s) 1-5, 7, 21, and 27-28 is/are rejected under 35 U.S.C. 103 as being unpatentable over Philippe et al (US 20130076898 A1) in view of Blendinger et al (US 20190050984 A1) for the same reasons as set forth in the last Office Action. Claim 6 is rejected under 35 U.S.C. 103 as being unpatentable over Philippe et al (US 20130076898 A1) in view of Blendinger et al (US 20190050984 A1) and Owsley et al (US 20170200206 A1) for the same reasons as set forth in the last Office Action. Claims 8-9, 13-15, 17-18, and 20, 22-25 is/are rejected under 35 U.S.C. 103 as being unpatentable over Philippe et al (US 20130076898 A1) in view of Blendinger et al (US 20190050984 A1) and Wolf et al (US 10729502 B1) for the same reasons as set forth in the last Office Action. Claim 11 is rejected under 35 U.S.C. 103 as being unpatentable over Philippe et al (US 20130076898 A1) in view of Blendinger et al (US 20190050984 A1) and Wolf et al (US 10729502 B1) and Soni et al (US 11720647 B2) for the same reasons as set forth in the last Office Action. Claim 12 is rejected under 35 U.S.C. 103 as being unpatentable over Philippe et al (US 20130076898 A1) in view of Blendinger et al (US 20190050984 A1) and Wolf et al (US 10729502 B1) and Peine et al (NPL: A Deep Learning Approach for Managing Medical Consumable Materials in Intensive Care Units via Convolutional Neural Networks: Technical Proof-of-Concept Study) for the same reasons as set forth in the last Office Action. Claim 26 is rejected under 35 U.S.C. 103 as being unpatentable over Philippe et al (US 20130076898 A1) in view of Blendinger et al (US 20190050984 A1) and Ingle (US 20190238791 A1) for the same reasons as set forth in the last Office Action. Response to Arguments Applicant's arguments filed 6/22/2026 have been fully considered but they are not persuasive. Applicant’s core arguments are directed to independent claims 1 and 21. Applicant asserts the following (Remarks, p. 4): PNG media_image1.png 332 860 media_image1.png Greyscale Examiner respectfully disagrees. Independent claims 1 and 21 as recited, involves image evaluation for shape recognition of a medical consumable (e.g., medical device). This shape recognition is then fed to an image analyzing means as “classification information” about said medical consumable i.e., identifying said medical consumable. It should be noted that claims 1 and 21 do not “classify” a medical consumable. Consequently, the prior art rejection in the last Office Action reasonably addressed the shape evaluation and identification of a medical consumable (device) as claimed in cited paragraphs 32, 45-50. Moreover, the examiner did acknowledge that Philippe ‘898 does not teach the last step of the claim 1 which recites “generating audio information based on the classification information in order to initiate an acoustic output of the audio information via an audio device”. Broadly speaking, the phrase “based on” implies many interpretations, however, the examiner recognized that the inventive concept of the present application is to produce an audible announcement of the identified medical consumable in the image. As such, Blendinger ‘984 was appropriately applied as secondary teaching for the specific aspect of producing an audible output “based on” an identified medical object in the image. At the time of effective filing, it would have been obvious to incorporate the teaching of Blendinger ‘984 into Philippe ‘898 to derived at claim 1 (21). Therefore, the rejections of claims 1 and 21 are maintained. Dependent claims 2-9, 11-15, 17, 18, 20, and 28 stand and fall with claims 1 and 21 respectively. Allowable Subject Matter Claims 10, 16, and 19 as amended into independent claims are now allowable. Conclusion THIS ACTION IS MADE FINAL. Applicant is reminded of the extension of time policy as set forth in 37 CFR 1.136(a). A shortened statutory period for reply to this final action is set to expire THREE MONTHS from the mailing date of this action. In the event a first reply is filed within TWO MONTHS of the mailing date of this final action and the advisory action is not mailed until after the end of the THREE-MONTH shortened statutory period, then the shortened statutory period will expire on the date the advisory action is mailed, and any nonprovisional extension fee (37 CFR 1.17(a)) pursuant to 37 CFR 1.136(a) will be calculated from the mailing date of the advisory action. In no event, however, will the statutory period for reply expire later than SIX MONTHS from the mailing date of this final action. The prior art made of record and not relied upon is considered pertinent to applicant's disclosure: US 20210015554 A1 US 20140032222 A1 US 20030025602 A1 Contact Information Any inquiry concerning this communication or earlier communications from the examiner should be directed to VU LE whose telephone number is (571)272-7332. The examiner can normally be reached M-F 8:00 - 17:00. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. Vu Le can be reached at 2-7332. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /VU LE/ Supervisory Patent Examiner, Art Unit 2668
Read full office action

Prosecution Timeline

Feb 02, 2024
Application Filed
Jan 21, 2026
Non-Final Rejection mailed — §101, §103
Jun 22, 2026
Response Filed
Jul 30, 2026
Final Rejection mailed — §101, §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12700224
METHOD, COMPUTER DEVICE, AND STORAGE MEDIUM, FOR FEATURE FUSION MODEL TRAINING AND SAMPLE RETRIEVAL
2y 11m to grant Granted Aug 04, 2026
Patent 12694573
V3C or Other Video-Based Coding Patch Correction Vector Determination, Signaling, and Usage
3y 4m to grant Granted Jul 28, 2026
Patent 12651321
IMAGE PROCESSING METHOD AND APPARATUS WITH IMAGE DEBLURRING
2y 10m to grant Granted Jun 09, 2026
Patent 12614032
IMAGE PROCESSING APPARATUS, IMAGE PROCESSING METHOD, AND STORAGE MEDIUM THAT DIVIDE SCANNED IMAGE DATA INCLUDING PAGE IMAGES OBTAINED BY SCANNING A PLURALITY OF DOCUMENTS FOR EACH PAGE INTO IMAGE DATA OF EACH DOCUMENT
3y 6m to grant Granted Apr 28, 2026
Patent 12602748
AUTOMATICALLY ENHANCING IMAGE QUALITY IN MACHINE LEARNING TRAINING DATASET BY USING DEEP GENERATIVE MODELS
2y 10m to grant Granted Apr 14, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

3-4
Expected OA Rounds
52%
Grant Probability
60%
With Interview (+7.9%)
2y 12m (~5m remaining)
Median Time to Grant
Moderate
PTA Risk
Based on 42 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month